SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Spectris plc (SEPJF) trades at a trailing P/E of 22.5, forward P/E of 29.9. Trailing earnings yield is 4.44%, forward earnings yield 3.35%. PEG 0.34 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (22.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.34); earnings yield beats bond yields (4.44%).
- PEG Ratio 0.34 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.44% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 75/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SEPJF
Valuation Multiples
P/E (TTM)22.5
Forward P/E29.9
PEG Ratio0.34
Forward PEG3.02
P/B Ratio0.00
P/S Ratio4.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.31
Forward EPS (Est.)$1.74
Book Value / Share$0.00
Revenue / Share$12.85
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.44%
Forward Earnings Yield3.35%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.95 |
$1.19B |
$113.8M |
9.6% |
| 2016 |
$0.09 |
$1.35B |
$10.3M |
0.8% |
| 2017 |
$1.96 |
$1.53B |
$234.8M |
15.4% |
| 2018 |
$1.57 |
$1.6B |
$185.2M |
11.5% |
| 2019 |
$2.02 |
$1.63B |
$234.1M |
14.3% |
| 2020 |
$-0.15 |
$1.34B |
$-17M |
-1.3% |
| 2021 |
$3.04 |
$1.16B |
$346.9M |
29.9% |
| 2022 |
$1.15 |
$1.33B |
$125M |
9.4% |
| 2023 |
$1.39 |
$1.45B |
$145.4M |
10% |
| 2024 |
$2.31 |
$1.3B |
$233.2M |
18% |
